CA3094737A1 - Oral delivery method for calcium carbonate - Google Patents

Oral delivery method for calcium carbonate Download PDF

Info

Publication number
CA3094737A1
CA3094737A1 CA3094737A CA3094737A CA3094737A1 CA 3094737 A1 CA3094737 A1 CA 3094737A1 CA 3094737 A CA3094737 A CA 3094737A CA 3094737 A CA3094737 A CA 3094737A CA 3094737 A1 CA3094737 A1 CA 3094737A1
Authority
CA
Canada
Prior art keywords
tablet
calcium carbonate
weight
amount
mastication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3094737A
Other languages
English (en)
French (fr)
Inventor
Jesper Neergaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fertin Pharma AS
Original Assignee
Fertin Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma AS filed Critical Fertin Pharma AS
Publication of CA3094737A1 publication Critical patent/CA3094737A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3094737A 2018-03-23 2019-03-21 Oral delivery method for calcium carbonate Pending CA3094737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/933,942 2018-03-23
US15/933,942 US10980831B2 (en) 2018-03-23 2018-03-23 Solid pharmaceutical tablet
PCT/DK2019/050100 WO2019179589A1 (en) 2018-03-23 2019-03-21 A solid pharmaceutical tablet

Publications (1)

Publication Number Publication Date
CA3094737A1 true CA3094737A1 (en) 2019-09-26

Family

ID=65995450

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3094737A Pending CA3094737A1 (en) 2018-03-23 2019-03-21 Oral delivery method for calcium carbonate

Country Status (10)

Country Link
US (3) US10980831B2 (https=)
EP (2) EP3768248B1 (https=)
JP (1) JP7303211B2 (https=)
CN (1) CN111902135A (https=)
AU (2) AU2019239514B2 (https=)
BR (1) BR112020018025A2 (https=)
CA (1) CA3094737A1 (https=)
ES (1) ES2951267T3 (https=)
PL (1) PL3768248T3 (https=)
WO (1) WO2019179589A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025230986A1 (en) * 2024-04-29 2025-11-06 Anju Majeed Aqueous dispersion of molecules-process, formulation and method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4753805A (en) 1984-01-31 1988-06-28 Warner-Lambert Company Tabletted chewing gum composition and method of preparation
ZA87994B (en) 1986-02-27 1987-09-30 Warner Lambert Co Antacid chewing gum
JPH0695888B2 (ja) * 1989-10-18 1994-11-30 株式会社サンギ カルシウム補給用チューインガム
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
EP1173154A4 (en) * 1999-04-15 2003-07-23 Wrigley W M Jun Co CHEWING GUM FOR DENTAL CARE, WHICH CONTAINS CALCIUM IN A PLEASANT ACID
US7244455B2 (en) 2002-01-16 2007-07-17 Warner-Lambert Company Center-filled chewing gum containing a deliverable form of calcium
EP1495680A1 (en) 2003-07-08 2005-01-12 Gum Base Co. S.p.A. Gum base for chewing gum
WO2006000233A1 (en) * 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
DK1765304T4 (da) * 2004-07-06 2019-06-03 Fertin Pharma As Komprimattyggegummitablet
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
MX2009008997A (es) 2007-02-26 2010-01-20 Revolymer Ltd Goma de mascar medicada.
WO2015070875A1 (en) 2013-11-15 2015-05-21 Fertin Pharma A/S Chewing gum suitable for diabetics
US10426726B2 (en) 2014-04-08 2019-10-01 Fertin Pharma A/S Medical chewing gum
GB2542192A (en) * 2015-09-11 2017-03-15 Revolymer (Uk) Ltd Chewable medicament
CA3000770A1 (en) 2015-10-07 2017-04-13 Fertin Pharma A/S Chewing gum comprising nicotine
ITUA20163230A1 (it) * 2016-05-06 2017-11-06 Perfetti Van Melle Spa Gomma da masticare con stevia
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Also Published As

Publication number Publication date
AU2019239514A1 (en) 2020-10-29
EP3831368A1 (en) 2021-06-09
EP3768248C0 (en) 2023-06-14
EP3768248B1 (en) 2023-06-14
US20190290684A1 (en) 2019-09-26
PL3768248T3 (pl) 2023-08-28
ES2951267T3 (es) 2023-10-19
US11730757B2 (en) 2023-08-22
CN111902135A (zh) 2020-11-06
EP3768248A1 (en) 2021-01-27
AU2019239514B2 (en) 2024-02-01
WO2019179589A1 (en) 2019-09-26
JP2021518412A (ja) 2021-08-02
US11723918B2 (en) 2023-08-15
US20210023128A1 (en) 2021-01-28
AU2024202892B2 (en) 2025-01-16
US20210205355A1 (en) 2021-07-08
JP7303211B2 (ja) 2023-07-04
AU2024202892A1 (en) 2024-05-23
US10980831B2 (en) 2021-04-20
BR112020018025A2 (pt) 2020-12-22

Similar Documents

Publication Publication Date Title
CN106456560B (zh) 医用口香糖
US6949264B1 (en) Nutraceuticals or nutritional supplements and method of making
US7678387B2 (en) Drug delivery systems
KR101168348B1 (ko) 압착된 츄잉 검 정제
US8858919B2 (en) Method of providing fast relief to a user of a nicotine chewing gum
US20130022675A1 (en) Drug delivery system
US6569472B1 (en) Coated chewing gum products containing antacid and method of making
KR20210013551A (ko) 활성 약학적 성분에 적합한 정제형 츄잉 검
US6541048B2 (en) Coated chewing gum products containing an acid blocker and process of preparing
US6645535B2 (en) Method of making coated chewing gum products containing various antacids
AU2024202892B2 (en) A solid pharmaceutical tablet
US20070059367A1 (en) Drug Delivery System and Associated Methods
US6663849B1 (en) Antacid chewing gum products coated with high viscosity materials
CA2355779C (en) Improved release of medicament active agents from a chewing gum coating
US20100196466A1 (en) Drug delivery system

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220909

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20241002

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250129

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250314

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250314

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250314

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250514

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250514

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260126

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260128